These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30109712)

  • 21. Probing the GnRH receptor agonist binding site identifies methylated triptorelin as a new anti-proliferative agent.
    Morgan K; Leighton SP; Millar RP
    J Mol Biochem; 2012 Jun; 1(2):86-98. PubMed ID: 24490142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
    Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
    J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone.
    Rahimipour S; Ben-Aroya N; Fridkin M; Koch Y
    J Med Chem; 2001 Oct; 44(22):3645-52. PubMed ID: 11606129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro evaluation of an 111In-labeled ST-peptide enterotoxin (ST) analogue for specific targeting of guanylin receptors on human colonic cancers.
    Gali H; Sieckman GL; Hoffman TJ; Kiefer GE; Chin DT; Forte LR; Volkert WA
    Anticancer Res; 2001; 21(4A):2785-92. PubMed ID: 11724355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen.
    Günthert AR; Gründker C; Olota A; Läsche J; Eicke N; Emons G
    Eur J Endocrinol; 2005 Oct; 153(4):613-25. PubMed ID: 16189183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, enzymatic stability and in vitro cytostatic effect of Daunorubicin-GnRH-III derivative dimers.
    Schreier VN; Mező G; Orbán E; Dürr C; Marquardt A; Manea M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2145-50. PubMed ID: 23434423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
    Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
    Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
    Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
    Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
    Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
    Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.
    Shirmardi SP; Gandomkar M; Maragheh MG; Shamsaei M
    Cancer Biother Radiopharm; 2011 Jun; 26(3):309-16. PubMed ID: 21711115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high affinity gonadotropin-releasing hormone (GnRH) tracer, radioiodinated at position 6, facilitates analysis of mutant GnRH receptors.
    Flanagan CA; Fromme BJ; Davidson JS; Millar RP
    Endocrinology; 1998 Oct; 139(10):4115-9. PubMed ID: 9751490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of a novel (177)Lu-DOTA-[Gly(3)-cyclized(Dap(4), (d)-Phe(7), Asp(10))-Arg(11)]α-MSH(3-13) analogue for melanocortin-1 receptor-positive tumor targeting.
    Lim JC; Hong YD; Kim JJ; Choi SM; Baek HS; Choi SJ
    Cancer Biother Radiopharm; 2012 Oct; 27(8):464-72. PubMed ID: 22831553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S; Laverman P; Joosten L; Eek A; Oyen WJ; de Jong M; Rutjes FP; van Delft FL; Boerman OC
    Bioconjug Chem; 2010 Apr; 21(4):663-70. PubMed ID: 20302291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice.
    Ho CL; Chen LC; Lee WC; Chiu SP; Hsu WC; Wu YH; Yeh CH; Stabin MG; Jan ML; Lin WJ; Lee TW; Chang CH
    Cancer Biother Radiopharm; 2009 Aug; 24(4):435-43. PubMed ID: 19694578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
    Koumarianou E; Loktionova NS; Fellner M; Roesch F; Thews O; Pawlak D; Archimandritis SC; Mikolajczak R
    Appl Radiat Isot; 2012 Dec; 70(12):2669-76. PubMed ID: 23037921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An assessment tumor targeting ability of (177)Lu labeled cyclic CCK analogue peptide by binding with cholecystokinin receptor.
    Cho EH; Lim JC; Lee SY; Jung SH
    J Pharmacol Sci; 2016 Jul; 131(3):209-14. PubMed ID: 27430985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells.
    Zhao LJ; Liu N; Li XP; Wang JL; Wei LH
    Chin Med J (Engl); 2010 May; 123(9):1170-5. PubMed ID: 20529558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats.
    Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
    Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Backbone metal cyclization: novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer.
    Barda Y; Cohen N; Lev V; Ben-Aroya N; Koch Y; Mishani E; Fridkin M; Gilon C
    Nucl Med Biol; 2004 Oct; 31(7):921-33. PubMed ID: 15464394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.